Coronary Heart Disease || Catheter-Based Coronary Angiography
- 作者Vlodaver, Zeev; Wilson, Robert F.; Garry, Daniel J.
- 文件大小3168.58KB
- 发表时间2012
- DOI10.1007/978-1-4614-1475-9_6
- 页码97-124
Attenuation of Interleukin-8 Expression in C6-deficient Rabbits After Myocardial Ischemia/ReperfusionKenneth S Kilgore; James L Park; Elaine J Tanhehco; Erin A Booth; Rory M Marks; Benedict R Lucchesi · 1998
Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotectionElaine J Tanhehco; Heekyung Lee; Benedict R Lucchesi · 2000
Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit HeartGralinski, Michael R.; Chi, Liguo; Park, James L.; Friedrichs, Gregory S.; Tanhehco, Elaine J.; McCormack, James G.; Lucchesi, Benedict R. · Journal of Cardiovascular Pharmacology and Therapeutics · 1996
Inhibitors of the anaplastic lymphoma kinaseMologni, Luca · Expert Opinion on Investigational Drugs · 2012
Melatonin in cardiovascular diseaseDominguez-Rodriguez, Alberto · Expert Opinion on Investigational Drugs · 2012
Drugs for bone healingBrandi, Maria Luisa · Expert Opinion on Investigational Drugs · 2012
Rheumatoid arthritis: developing pharmacological therapiesMoreland, Larry W; Misischia, Richard J · Expert Opinion on Investigational Drugs · 2002
New and investigational antiepileptic drugsStriano, Pasquale; Striano, Salvatore · Expert Opinion on Investigational Drugs · 2009
Ertapenem: a new carbapenemOdenholt, Inga · Expert Opinion on Investigational Drugs · 2001
Recent developments in carbapenemsNicoletti, Giuseppe; Russo, Giovanni; Bonfiglio, Giovanni · Expert Opinion on Investigational Drugs · 2002
The immunotherapeutic potential of melatoninMaestroni, Georges JM · Expert Opinion on Investigational Drugs · 2001